Skip to main content
eScholarship
Open Access Publications from the University of California

UCLA

UCLA Electronic Theses and Dissertations bannerUCLA

Vasoactive Intestinal Polypeptide (VIP) Regulates Metabolic Processes in Human and Murine Adipocytes by Modulating PPARγ Expression

  • Author(s): Luong, Leon;
  • Advisor(s): Tidball, James G;
  • Pisegna, Joseph R
  • et al.
Abstract

Vasoactive intestinal peptide (VIP) is a neuropeptide expressed centrally in the hypothalamus and peripherally in the GI tract and adipose tissue. VIP and its VPAC receptors regulate body composition, as implicated by pathway-based, genome-wide association studies. We have previously shown that VIP-/- mice have lower fat mass and higher lean mass than their wild-type littermates. To elucidate the role of VIP in fat mass accumulation, VIP-/- mice were fed a 45% high-fat diet for 12 weeks. We determined that VIP-/- mice were resistant to weight gain and fat mass accumulation and had altered feeding behaviors and metabolic hormone levels. VIP antagonism of differentiating pre-adipocytes inhibited induction of adipocyte-related genes, such as PPARγ and C/EBP. Genetic association analyses using data from the METAbolic Syndrome in Men (METSIM) study showed a positive correlation between VIP, VPAC1R and key genetic drivers of adipogenesis. These results implicate VIP’s role in modulating fat accumulation.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View